Clinical Trial Update: Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating high-dose rosuvastatin versus low-dose rosuvastatin plus ezetimibe on carotid plaque inflammation in acute coronary syndrome patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerotic Plaque with Inflammation
• Coronary Syndrome

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Yuhan Corporation | Conditions: Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With Inflammation | Phase 4 | Status: COMPLETED